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BRIEF DEFINITIVE REPORT
 From late stages in fetal development onward, 
tissue repair is always accompanied by a robust 
recruitment of infl ammatory cells to the wound 
site. Although this infl ammatory response is 
clearly necessary for defense against invading 
microbes, recent studies in several organisms 
have shown that it is not essential for the tissue 
repair process, per se, and may even be causal 
of a fi brotic response ( 1 ). This may contribute 
not only to scarring of skin wounds, but may 
also underlie fi brotic pathologies in other tis-
sues ( 2 – 4 ). Our recent analysis of tissue repair 
in PU.1-null mice, which lack neutrophils, 
macrophages, and mast cells, and therefore are 
genetically incapable of raising a standard in-
fl ammatory response, revealed a similar time 
course of wound healing to that of wild-type 
siblings, but PU.1-null wounds appear largely 
free of fi brosis as a consequence of this lack 
of infl ammation ( 5 ). Our microarray studies 
of wound tissues from wild-type mice versus 
PU.1-null siblings revealed a portfolio of genes 
that are expressed only in the presence of a ro-
bust infl ammatory response ( 6 ). One of these 
infl ammation-dependent genes was osteopon-
tin (OPN), which is expressed by wound gran-
ulation tissue fi broblasts coincident with the 
wound infl ammatory response. These data, along 
with microarray studies in other models that 
have shown elevated OPN expression in fi bro-
sis of other organ systems (e.g., lung [ 7 ] and liver 
[ 8 ]), support the idea that OPN may function-
ally contribute to infl ammation-associated fi -
brosis. OPN is known to act both as a secreted 
chemokine-like protein ( 9 ), as well as part of an 
intracellular signaling complex ( 10 ), depending 
on the cellular context. It has many and di-
verse cellular eff ects, including the capacity to 
regulate cell adhesion, migration, and survival, 
as well as several functions in immune regula-
tion, and a key role in the interplay between 
osteoblasts and osteoclasts as bone is remodeled 
( 11 ); yet OPN-null mice develop normally and 
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 Previous studies of tissue repair have revealed osteopontin (OPN) to be up-regulated in 
association with the wound infl ammatory response. We hypothesize that OPN may contrib-
ute to infl ammation-associated fi brosis. In a series of in vitro and in vivo studies, we ana-
lyze the effects of blocking OPN expression at the wound, and determine which 
infl ammatory cells, and which paracrine factors from these cells, may be responsible for 
triggering OPN expression in wound fi broblasts. Delivery of OPN antisense oligodeoxynucle-
otides into mouse skin wounds by release from Pluronic gel decreases OPN protein levels at 
the wound and results in accelerated healing and reduced granulation tissue formation and 
scarring. To identify which leukocytic lineages may be responsible for OPN expression, we 
cultured fi broblasts in macrophage-, neutrophil-, or mast cell – conditioned media (CM), and 
found that macrophage- and mast cell – secreted factors, specifi cally platelet-derived 
growth factor (PDGF), induced fi broblast OPN expression. Correspondingly, Gleevec, which 
blocks PDGF receptor signaling, and PDGF-R  – neutralizing antibodies, inhibited OPN 
induction by macrophage-CM. These studies indicate that infl ammation-triggered expres-
sion of OPN both hinders the rate of repair and contributes to wound fi brosis. Thus, OPN 
and PDGF are potential targets for therapeutic modulation of skin repair to improve heal-
ing rate and quality. 
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 RESULTS AND DISCUSSION 
 To address our hypothesis that infl ammation-dependent OPN 
expression in healing wounds may contribute to fi brosis and 
scarring, we sought to down-regulate its expression at the 
wound site. AS ODNs were designed and optimized (Sup-
plemental materials and methods, Table S1, and Fig. S1, available 
at http://www.jem.org/cgi/content/full/jem.20071412/DC1), 
and these, or a corresponding scrambled-sequence control 
ODN, were applied to in vivo 4-mm punch biopsy wounds 
on the backs of adult mice, at a concentration of 1   M 
in 30% Pluronic gel. Standardly, OPN is expressed in the 
wound granulation tissue by 6 h after wounding, with levels 
peaking at 3 d, and then diminishing to prewound levels by 
heal skin wounds with a similar time course to their wild-
type siblings, with only a slight alteration in matrix architec-
ture and collagen fi bril formation in the deep layers of the 
wound ( 12 ). 
 We report the consequences of acute local knockdown 
of OPN on skin wound healing using antisense oligode-
oxynucleotides (AS ODNs). We show that OPN AS ODN 
treatment leads to accelerated repair and decreased granu-
lation tissue and scar formation. We go on to show that it 
is macrophages, specifi cally macrophage-derived platelet-
derived growth factor (PDGF)-BB, which appear to be 
responsible for the infl ammation-induced OPN expression 
in wound fi broblasts. 
 Figure 1.  AS ODNs against OPN effi ciently decrease OPN protein levels in in vivo mouse wounds. (A) Immunostaining for OPN (brown) 
reveals expression by wound connective tissue cells at day 1 and 3, which is resolved by 7 d after wounding. (B) Double immunofl uorescence of 
wound tissue at 3 d reveals OPN expression (red) in both F4/80-positive (green; closed arrowheads) and -negative cells (open arrowheads). (C) West-
ern blot analysis of OPN in control- and OPN AS ODN – treated wound tissue confi rms the temporal profi le of the immunostaining in A, and indicates 
that AS ODN treatment leads to depletion of OPN. (D) Band intensities were quantifi ed by densitometric analysis on blots from six independent ex-
periments, and values for the OPN/GAPDH ratio are shown (mean  ± SEM). (E) Cy3-tagged OPN AS ODNs (red) were applied to wounds to assess to 
what depths and in which tissues OPN was being depleted (evaluated at 6 h). Dotted line indicates the epidermal/connective tissue interface, and 
the arrowhead indicates the epidermal wound edge. Inset shows a low-magnifi cation view of the same section. Bars: (A) 50   m; (B) 10   m; (E) 100   m; 
(E, inset) 200   m. 
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wounds at these time points (unpublished data). To visualize 
the uptake and localization of delivered ODNs, we generated a 
Cy3-tagged OPN AS ODN that shows uptake in a non – cell 
lineage – specifi c manner, extending up to 1 mm back from 
the wound margin and in cell layers up to 300   m deep 
within the wound ( Fig. 1 E ). 
 OPN AS ODN improves the rate and quality 
of wound healing 
 Macroscopic analyses of time-matched OPN knockdown 
versus control wounds showed that closure is markedly ac-
celerated at early time points during repair in OPN AS 
7 d ( Fig. 1 A ). Our immunofl uorescence studies with an-
tibodies against OPN and the macrophage-specifi c marker 
F4/80 indicate that although some wound macrophages ex-
press OPN at a low level, the majority of OPN-positive cells 
are F4/80 negative, and thus are mesenchymally derived and 
most likely fi broblasts, although we cannot exclude that some 
may be pericytes ( Fig. 1 B ). Western blot analyses of wound 
tissues indicate that our AS knockdown reproducibly reduced 
OPN levels to   25% of control levels at 6 h, and 50% of 
control levels by 3 d after wounding ( Fig. 1, C and D ). This 
reduction was consistent with reduced immunohistochemical 
(IHC) staining for OPN in sections from AS ODN – treated 
 Figure 2.  Skin wound healing is accelerated in OPN AS ODN – treated wounds. (A) A schematic diagram illustrating the location and dimensions 
of the full-thickness excisional and incisional wounds made to shaved dorsal skin of adult male ICR mice. Dotted lines indicate the axes of sections. 
(B) Macroscopic observation of excisional control- and OPN AS ODN – treated wounds at various time points after wounding. (C) The proportion of the wound 
remaining open relative to the initial wound area at each time point after the injury in control- (open bars) versus OPN AS ODN – treated (fi lled bars) 
wounds (mean  ± SEM;  n = 6). (D) Schematic to indicate measurements derived from histological sections. (E) Wound reepithialization at 3 and 7 d after 
wounding ( n = 9 for both). (F) Connective tissue wound width remaining after 3, 7, 10, and 14 d of repair in control- versus OPN AS ODN – treated wounds 
(day 3 and 7,  n = 9; day 10 and 14,  n = 6). (G) Expression of   -smooth muscle actin at 3 and 7 d using Western blotting. Images shown are representative 
of four independent experiments. (H) Tissue from excisional wounds was harvested at 14 d after wounding and stained with Masson ’ s Trichrome, and the 
extent (cross-sectional area) of granulation tissue was visualized and quantifi ed at the mid-point of the wound (indicated by dotted line). (I) The area of 
granulation tissue was signifi cantly decreased by OPN AS ODN treatment (fi lled bars), relative to control (open bars; day 3 and 7,  n = 9; day 10 and 14, 
 n = 6). Bars: (B and H) 1 mm. 
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tionally responsible for slower wound healing ( 13 ). Rather, 
it seems that OPN expressed by wound fi broblasts as a con-
sequence of signals from infl ammatory cells may hinder the 
rate of repair. 
 Sections of excisional wounds were stained with Masson ’ s 
Trichrome to reveal the cross-sectional area of wound granu-
lation tissue in the mid-wound region ( Fig. 2 H ). At all time 
points analyzed, OPN knockdown wounds had a consider-
ably reduced cross-sectional area of granulation tissue com-
pared with controls (at 10 and 14 d, 50% less;  Fig. 2, H and I ). 
These data implicate OPN expression at the wound site as 
being at least partially causal of the extensive granulation tis-
sue formation and subsequent fi brosis that we see during re-
pair of standard skin lesions. Our data do not distinguish 
whether OPN might be directly responsible for these changes 
or whether they are an indirect consequence of the reduced 
infl ammatory response. Although expression of OPN has 
previously been correlated with several fi brotic conditions in 
other anatomical sites (e.g., lung [ 7 ], liver [ 8 ], and heart [ 14 ]), 
ODN – treated wounds ( Fig. 2, B and C ), with a mean of 
56% of complete closure achieved by 3 d, compared with 
24% closure in controls. Histological analysis enables us to 
dissect the contributions made by reepithelialization and 
connective tissue contraction ( Fig. 2 D ) and indicates that 
reepithelialization, at least up to 3 d, is signifi cantly faster in 
OPN AS ODN – treated wounds ( Fig. 2 E ), and that connec-
tive tissue wound width is less than controls at all stages dur-
ing the healing process, suggesting enhanced connective 
tissue contraction from the earliest time points studied ( Fig. 
2 F ). In concord with this, we see   -smooth muscle actin, 
which is a marker of contractile myofi broblasts, expressed on 
day 3 in OPN AS ODN – treated wound sites, which is ear-
lier than in control wounds ( Fig. 2 G ). That AS ODN-treated 
wounds are capable of complete and effi  cient closure suggests 
that OPN does not play a pivotal role in skin repair, which is 
consistent with observations of wound repair in OPN-null 
mice ( 12 ), but opposes the interpretation that the lower 
OPN expression observed in a diabetic mouse model is func-
 Figure 3.  Altered collagen organization after OPN knockdown in wound sites . (A) Macroscopic views of scars of control- and OPN AS ODN –
 treated incisional wounds at 21 d after injury. *, wound edge. Images shown are representative of eight independent experiments. (B) Picrosirius red –
 stained sections of control- and OPN AS ODN – treated incisional wounds at 21 d. Representative of fi ve independent experiments. High-magnifi cation 
details from boxed areas indicated are differential interference contrast images. Arrowheads show wound edge. (C) TEM images of connective tissue from 
unwounded skin, control-, and AS ODN – treated 14 d wounds. Higher magnifi cation insets illustrate differing collagen fi bril diameters in these tissues. 
(D) Graphic representation of the mean diameter of collagen fi brils ( ± the SEM) from at least 5 fi elds of view of intact, unwounded skin, control ODN-, 
and OPN AS ODN – treated wounds; unwounded skin (striped bar,  n = 200), control ODN (open bar,  n = 300), OPN AS ODN (fi lled bar,  n = 150). Bars: 
(B; low magnifi cation) 100   m; (B; high magnifi cation) 25   m; (C) 1   m; (C, inset) 100 nm. 
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to infl uence various aspects of repair, and we observe that the 
numbers of both of these cell types are signifi cantly reduced 
as a consequence of OPN AS ODN treatment at times when 
their numbers are peaking in control wounds (i.e., 1 d for 
neutrophils and 7 d for macrophages;  Fig. 4, A and B ). Our 
data are consistent with other in vivo evidence that OPN 
may function as a chemoattractant for neutrophil and macro-
phage lineages ( 18 ). Mast cells, which are also implicated in 
tissue remodeling at wound sites ( 19 ), exhibit reduced num-
bers by comparison to control wounds at 10 d ( Fig. 4, A and B ). 
Associated with these reduced numbers of infl ammatory cells 
at the wound site are reduced levels of mRNA encoding the 
potent infl ammatory cell chemoattractant, Ccl2, as well as 
TGF  1 ( Fig. 4 C ), suggesting that a positive feedback loop 
leading to amplifi cation of the infl ammatory episode may be 
disrupted by OPN knockdown. 
 Altered extracellular matrix deposition and angiogenesis 
in OPN AS ODN – treated wounds 
 The reduced extent of granulation tissue in OPN knock-
down wounds and the associated down-regulation of  TGF  1 
(a major fi brogenic factor during skin wound healing [ 20 ]) led 
us to investigate alterations in matrix deposition at the wound 
site. We show that fi bronectin and type I collagen   1 mRNA 
are reduced at OPN AS ODN – treated wounds, and that the 
wound-induced metalloproteinase, MMP9, is also expressed 
at signifi cantly lower levels from 7 d on ( Fig. 4 C ). 
 Angiogenesis is intimately associated with granulation tis-
sue formation during wound repair. We have evaluated an-
giogenesis by IHC for platelet/endothelial cell adhesion 
molecule 1 (CD31) in control and OPN AS ODN wounds. 
OPN AS ODN led to signifi cantly increased numbers of 
vessel lumens in the mid-granulation tissue zone at 7 d after 
wounding compared with control wounds ( Fig. 4 D and E ). 
This diff erence in the extent of wound vascularity was re-
solved by 14 d, and suggests an increased rate of vessel inva-
sion at early time points in the repair process. This appears 
not to be caused by altered levels of the wound angiogenic 
factor vascular endothelial growth factor, as we see no signifi -
cant diff erence in OPN AS ODN – treated wounds in this re-
gard (unpublished data). Recent evidence suggests that OPN 
has the capacity to directly inhibit angiogenesis ( 21 ), but we 
also note that during repair of skin wounds in PU.1-null 
mice, where there is no infl ammatory response and reduced 
scarring, there is also signifi cantly increased vascularity within 
wound granulation tissue ( 5 ). Similarly, TNF-Rp55 knock-
out mice that lack TNF-  – mediated signaling display in-
creased angiogenesis at skin wound sites ( 22 ). These results 
indicate that the infl ammatory response and infl ammatory 
cytokines may negatively regulate angiogenesis, and this may 
encourage fi brosis during normal wound repair. 
 Infl ammation-dependent regulation of OPN expression 
is mediated largely by macrophages 
 Our recent comparison of the gene expression profi les of 
tissue repair in wild-type versus PU.1-null mice revealed that 
this study of skin repair is the fi rst functional demonstration 
that OPN expression may contribute to fi brosis. 
 Altered collagen organization at OPN AS ODN – treated 
wound sites 
 To address whether knockdown of OPN infl uences the level 
of scarring resulting from the repair process, we turned to 1-
cm incisional wounds, which were monitored daily for up to 
3 wk. Macroscopic analyses 21 d after injury showed that the 
control wounds developed a thin linear white scar, which was 
noticeably reduced in OPN knockdown wounds ( Fig. 3 A ). 
To further compare developing scar tissue in control- and 
OPN AS ODN – treated wounds, Picrosirius red staining and 
transmission electron microscopy (TEM) analysis of 3 wk 
wound sections were undertaken to reveal gross collagen 
bundling patterns and ultrastructural analysis of individual 
collagen fi bril diameter and density of fi brils in wound con-
nective tissues, respectively ( Fig. 3, B – D ). The Picrosirius red 
histology revealed less dense  “ scar collagen ” in the OPN AS 
ODN – treated wounds ( Fig. 3 B ), and our ultrastructural 
studies showed more  “ vacant ” extracellular space (i.e., space 
between the collagen fi brils and between bundles), such that 
153 nm 2 /  m 2 of the cross-sectional area through the mid-
region of AS ODN – treated wounds was  “ empty ” of collagen 
fi bers compared with 114 nm 2 /  m 2 in control ODN-treated 
wounds, and 132 nm 2 /  m 2 in unwounded skin ( Fig. 3 C ). 
Moreover, a signifi cant reduction in collagen fi bril diameter 
was observed in OPN AS ODN – treated wounds in compari-
son to controls, both of which displayed smaller diameters 
than unwounded skin (56 nm vs. 81 nm vs. 114 nm, respec-
tively;  Fig. 3, C and D ). We speculate that these diff erences 
in collagen fi bril diameter and bundling density at the wound 
site may refl ect and give rise to the later diff erences in extent 
of fi brosis seen in OPN AS ODN – treated wounds. 
 Collagen fi brillogenesis is known to be regulated by sev-
eral enzymes, including members of the ADAMTS family, 
BMP1, and the mammalian tolloids, as well as by interaction 
with extracellular matrix proteins ( 15 ). Our observations, to-
gether with data from OPN-null mice where the diameter of 
collagen fi brils at deep dermal wound sites are also smaller 
than in wild-type mice ( 12 ), suggest that this process may also 
be aff ected by OPN. Indeed, it has been reported that OPN 
interacts directly with collagen type I and III, which are the 
chief isoforms of intact and repairing skin connective tissue, 
respectively ( 16 ). Alternatively, OPN could aff ect collagen 
fi bril formation indirectly, e.g., by altering fi bronectin levels, 
which we demonstrate are reduced in AS OPN-treated wounds 
( Fig. 4 C ). Studies of fi bronectin-null fi broblasts have shown 
that the interaction of these two molecules is a key step in 
collagen assembly ( 17 ). 
 Leukocyte recruitment is signifi cantly reduced in OPN AS 
ODN – treated wounds 
 Several lineages of infl ammatory cells are recruited to sites of 
tissue damage with overlapping time courses during the re-
pair process. Both neutrophils and macrophages are known 
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repair ( Fig. 4 ) ( 19, 23 ). We reasoned that macrophages are 
likely to be providing the major inductive signal for OPN up-
regulation during in vivo healing, although our data do not 
rule out a contribution from mast cells. Six growth-factors/
cytokines known to be secreted by macrophages ( 24 ) were 
then tested for their ability to induce OPN expression in Swiss 
3T3s. PDGF-BB, but not EGF, TGF  1, TGF  3, IL-6, or 
TNF-  , was able to signifi cantly up-regulate OPN expression 
( Fig. 5 C ). To confi rm that PDGF was, indeed, mediating the 
macrophage-CM induction of OPN, we suppressed PDGF-
R signaling with Gleevec or PDGF-R  neutralizing anti-
bod ies during fi broblast exposure to macrophage CM ( Fig. 5, 
D and E ), and showed that OPN expression was signifi cantly 
reduced. Induction of OPN could similarly be blocked with 
wortmannin ( Fig. 5 F ), which implicates the PI3K signaling 
cascade down-stream of PDGF in transducing this signal. 
In an in vivo setting, release of PDGF by degranulating platelets 
OPN is an infl ammation-dependent repair gene, but because 
the PU.1-null mice lack neutrophils, macrophages, and mast 
cells, it was unclear which of these leukocytic lineages might 
be responsible for inducing OPN expression in the normal 
repair situation. To address this, Swiss 3T3 fi broblasts were 
cultured in the presence of conditioned media (CM) from 
equal numbers of J774.1 macrophages, primary mouse neu-
trophils, RBL mast cells, or primary bone marrow – derived 
macrophages ( Fig. 5 A ). Western blot analysis showed that 
factors secreted by all macrophages tested, and mast cells, but 
not neutrophils, can trigger 3T3 fi broblast expression of OPN 
( Fig. 5 B ). Normal human dermal fi broblasts similarly respond 
to macrophage-CM with a robust up-regulation of OPN 
(unpublished data). Induction of OPN expression in in vivo 
wounds coincides temporally with the fi rst infl ux of macro-
phages to the wound, whereas mast cell numbers peak much 
later after injury, and are relatively few in number throughout 
 Figure 4.  Knockdown of OPN dampens the recruitment of infl ammatory cells and increases neovascularization. (A) Immunohistochemistry 
(IHC) for myeloperoxidase (neutrophils) and F4/80 (macrophages) or Toluidine blue staining (mast cells) reveals signifi cantly fewer leukocytes in the 
wound granulation tissue of AS ODN – treated versus control wounds. (B) The number of neutrophils, macrophages, and mast cells at wound sites were 
quantifi ed for control- (open bars) and OPN AS ODN – treated wounds (fi lled bars; mean  ± SEM;  n  ≥ 5). (C) Real-time RT-PCR analysis determined the ex-
pression of Ccl2, TGF  1, fi bronectin, collagen type1  1, and MMP9 at wound sites, relative to GAPDH, in control ODN (open bars) and OPN AS ODN 
wounds (fi lled bars; mean  ± SEM;  n = 9). (D) CD31/platelet/endothelial cell adhesion molecule 1 IHC reveals blood vessels in control- (left) and OPN AS 
ODN – treated wounds (right) at 7 d after injury (original wound margins indicated by arrowheads). (E) Graphical representation of the number of vessel 
lumens in the central wound granulation zone at 7 and 14 d. Bars: (low magnifi cation) 200   m; (high magnifi cation) 50   m. 
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 Although OPN expression at sites of tissue repair appears 
to have largely detrimental consequences on healing, the same 
is not true for PDGF, as highlighted by the observation that 
Gleevec treatment delivered from the outset of the repair 
process signifi cantly slows wound closure ( 25 ). Indeed, topical 
application of PDGF-BB to wounds has been successful in 
accelerating the healing of chronic ulcers ( 26 ), but there is 
evidence that this improvement in healing speed is accompa-
nied by increased granulation tissue and scarring ( 27 ). We 
propose that these negative side-eff ects may be attributable to 
PDGF-induced OPN expression, and we further speculate 
that down-regulation of OPN may be a molecular mecha-
nism by which Gleevec reduces pulmonary and dermal fi -
brosis ( 28, 29 ). Clearly, any clinical eff orts to therapeutically 
dampen PDGF signaling to improve the quality of tissue 
repair would require careful consideration of ways that would 
enable positive contributions while blocking the later  “ fi brotic ” 
infl uence. Fibrosis is likely to be a multifactorial driven process, 
and, accordingly, we are not suggesting that macrophage-
secreted PDGF and consequent OPN induction alone are 
responsible for wound fi brosis. There is considerable evidence 
that the balance of TGF  isoforms, for example, is also criti-
cal in directing the extent of scarring at a healing skin wound 
( 30 ). However, our studies indicate that neither TGF  1 nor 
  3 is the inductive signal responsible for triggering OPN 
expression by wound fi broblasts; yet acute knockdown of OPN 
improves both the rate of healing and the eventual quality of 
the repair. 
 Together, our in vivo wound studies and tissue culture 
experiments indicate that infl ammatory cell-mediated sig-
nals (we have identifi ed macrophage-derived PDGF as a 
likely player) trigger expression of OPN in wound fi bro-
blasts, and this may both retard repair and be partially re-
sponsible for the fi brosis resulting from wound healing. 
How OPN expression might lead to increased fi brosis is 
not yet clear, but our data hint that it may have pleiotropic 
eff ects, infl uencing wound angiogenesis, amplifying the in-
fl ammatory response, and possibly even directly modulating 
the expression of matrix genes in fi broblasts (although pre-
liminary in vitro studies with 3T3 fi broblasts indicate that 
neither collagen nor fi bronectin expression levels are sig-
nifi cantly altered directly upon OPN exposure). Further 
studies will indicate which of these predominates and how 
this may infl uence the  “ window of opportunity ” for thera-
peutic intervention. 
 MATERIALS AND METHODS 
 Wound model and ODN treatment.  All experiments were conducted 
according to UK Home Offi  ce regulations. Mice (ICR age-matched males; 
7 – 11 wk old) were halothane-anaesthetized, and four full-thickness exci-
sional wounds (4-mm biopsy punch; Kai Industries) or two full-thickness 
incisional wounds of 1 cm were aseptically made to the shaved dorsal skin 
( Fig. 2 A ). ODNs (control or OPN AS; described in Table S2, available at 
http://www.jem.org/cgi/content/full/jem.20071412/DC1) were topically 
applied by pipette into the wound cavity immediately after wounding (50  μ l; 
1, 2, or 5   M in 30% Pluronic F-127 gel [see Supplemental materials and 
methods]; Sigma-Aldrich). Wounds were recorded using a microscope (Ste-
REO Lumar.V12; Carl Zeiss, Inc.), and areas were calculated using Openlab 
occurs immediately, but transiently, after injury, and is sub-
sequently supplemented by local up-regulation by resident 
wound cells and invading macrophages. We performed a time 
course experiment to address the minimum window of expo-
sure to PDGF required for OPN expression, and our data 
suggest that OPN levels peak   8 h after initial exposure and 
require at least a 2-h window of exposure ( Fig. 5 G ). These 
fi ndings, considered together with our observation that PU.1-
null mice, which have normal platelet biology, but do not ex-
press OPN in wounds ( 6 ), suggest that platelet-derived PDGF 
exposure is not suffi  cient on its own to induce OPN expres-
sion; rather, sustained exposure of fi broblasts to macrophage-
derived PDGF is responsible for the OPN induction that we 
observe in vitro , and by implication, in vivo as well. 
 Figure 5.  Regulation of OPN expression by infl ammatory cells. 
(A) Schematic diagram of our in vitro assay to determine which leuko-
cytes and which secreted factors are responsible for induction of OPN 
expression in fi broblasts. Western blot analyses of Swiss 3T3 fi broblast 
cells treated for 8 h with CM from various leukocytic cell lineages (B) or 
EGF, PDGF-BB, TGF  1, TGF  3, IL-6, or TNF-  (C) to determine which con-
ditions lead to increased OPN expression. (D) Fibroblasts were cotreated 
with macrophage-CM and Gleevec, PDGF-R neutralizing antibodies (E), or 
wortmannin (F). (G) Swiss 3T3 fi broblasts were stimulated with 20 ng/ml 
PDGF-BB for the time indicated, and either immediately analyzed (left), or 
rinsed in fresh media and cultured for the remainder of 8 h before being 
analyzed for OPN expression (right). 
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